Search

Author/Creator Boquimpani, C.

1. PB1902: ASC4OPT TRIAL IN PROGRESS: A PHASE 3B OPEN-LABEL OPTIMIZATION STUDY OF ORAL ASCIMINIB IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE PREVIOUSLY TREATED WITH 2 OR MORE TYROSINE KINASE INHIBITORS. (23rd June 2022)

Authors:
Breccia, M.; Turkina, A.; Boquimpani, C.; Chuah, C.; Sharf, G.; Schuld, P.; Hoch, M.; Yssel, J.; Zhang, Y.; Hochhaus, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE. (23rd June 2022)

Authors:
Rea, D.; Hochhaus, A.; Mauro, M. J.; Minami, Y.; Lomaia, E.; Voloshin, S.; Turkina, A.; Kim, D.-W.; Apperley, J. F.; Cortes, J. E.; Abdo, A.; Fogliatto, L. M.; Kim, D. D. H; le Coutre, P.; Saussele, S.; Annunziata, M.; Hughes, T. P.; Chaudhri, N.; Chee, L.; García-Gutiérrez, V.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment outcomes for Hodgkin's lymphoma patients aged 60 and older: A report from the Brazilian prospective Hodgkin's lymphoma registry. (June 2017)

Authors:
Biasoli, I.; Delamain, M.; Simoes, B.P.; Castro, N.; Gaiolla, R.; Solza, C.; Silveira, T.; Praxedes, M.; Farley, J.; Boquimpani, C.; Sola, C.B.; Clementino, N.; Perini, G.F.; Franceschi, F.; Chiattone, C.S.; Baioccchi, O.; Pagnano, K.; Tabacof, J.; Steffenello, G.; Soares, A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search